English
Home > Products > 55750-06-6

China 55750-06-6 Factory

"Sincerity, Innovation, Rigorousness, and Efficiency" may be the persistent conception of our organization for that long-term to establish jointly with customers for mutual reciprocity and mutual gain for 55750-06-6,CAS NO 55750-06-6,Imidocarb API,Imidocarb, We generally keep the philosophy of win-win, and develop long-term cooperation connection with buyers from around the planet.We feel that our expansion foundation on customer's achievement, credit rating is our daily life.
55750-06-6, Customer satisfaction is our goal. We're looking forward to cooperating with you and providing our best services in your case. We warmly welcome you to contact us and remember to feel free to contact us. Browse our online showroom to see what we can do for yourself. And then E-mail us your specifications or inquiries today.

Related Products

Hot Products

  • Methylprednisolone hemisuccinate

    Methylprednisolone hemisuccinate

    Product Name:Methylprednisolone hemisuccinate
    Molecular Formula:C26H34O8
    Molecular Weight;474.54
    CAS Registry Number;2921-57-5
  • Testosterone enanthate

    Testosterone enanthate

    Product Name:Testosterone enanthate
    Molecular Formula:C26H40O3
    Molecular Weight:400.59
    CAS Registry Number;315-37-7
  • 4'-Benzyloxy-2-bromopropiophenone

    4'-Benzyloxy-2-bromopropiophenone

    Product Name:4'-Benzyloxy-2-bromopropiophenone
    Molecular Formula:C16H15BrO2
    Molecular Weight:319.19
    CAS Registry Number:35081-45-9
  • Piperacilloic Acid

    Piperacilloic Acid

    Product Name:Piperacilloic Acid
    Molecular Formula:C23H29N5O8S
    Molecular Weight:535.57
    CAS Registry Number:64817-22-7
  • 2,3,4-Trifluorobenzoic acid

    2,3,4-Trifluorobenzoic acid

    Product Name:2,3,4-Trifluorobenzoic acid
    Molecular Formula:C7H3F3O2
    Molecular Weight:176.09
    CAS Registry Number:61079-72-9
  • Sugammagex

    Sugammagex

    Product Name:Sugammadex
    Molecular Formula:C72H112O48S8
    Molecular Weight;2002.15
    CAS Registry Number;343306-71-8
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 55750-06-6

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept